Lymphoma Trial, Recruiting (NCT06856226)

Lymphoma Trial, Recruiting NCT06856226 Sponsor: National Cancer Institute (NCI) Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT06856226 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

You must be 18 years old or older.
You must already be enrolled in another clinical trial at the NIH Clinical Center where you will either donate stem cells to someone or receive stem cells from a donor (known as a stem cell transplant from another person).
You and your stem cell donor (or recipient) must both sign up for this trial together, so that a complete set of samples can be collected from both of you.
You must be able to understand the study and be willing to sign a consent form agreeing to take part.

Who may not be able to join:

Donors cannot sign up for this trial without their recipient also enrolling at the same time.
You have previously received a stem cell transplant from another person.
You have a history of a psychiatric (mental health) condition that might make it difficult to follow the requirements of the study (confirm with trial site).
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher G Kanakry, M.D., National Cancer Institute (NCI)

Phone: (240) 921-4889

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06856226

Sponsor: National Cancer Institute (NCI)

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: (240) 921-4889

More information: https://clinicaltrials.gov/study/NCT06856226

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

You must be 18 years old or older.
You must already be enrolled in another clinical trial at the NIH Clinical Center where you will either donate stem cells to someone or receive stem cells from a donor (known as a stem cell transplant from another person).
You and your stem cell donor (or recipient) must both sign up for this trial together, so that a complete set of samples can be collected from both of you.
You must be able to understand the study and be willing to sign a consent form agreeing to take part.

Who may not be able to join:

Donors cannot sign up for this trial without their recipient also enrolling at the same time.
You have previously received a stem cell transplant from another person.
You have a history of a psychiatric (mental health) condition that might make it difficult to follow the requirements of the study (confirm with trial site).
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Cancer Institute (NCI)

Registry

ClinicalTrials.gov

Start date

4 March 2026

Est. completion

1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To determine the most reliable host genomic source for pharmacogenetic testing in participants that have received allogeneic hematopoietic stem cell transplant (HSCT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov